glp 1 and colonoscopy THE UNSEEN CONSEQUENCES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1RA) IN PATIENTS UNDERGOING UPPER ENDOSCOPY Save this #GLP1 checklist before

Tolerability and access, however, remain significant considerations

If one dose is missed and the next scheduled dose is less than 2 days away (48 hours), do not administer the dose

Reassuringly, pancreatitis remains a rare event in most patients on long-term GLP1 therapy

Lifestyle modifications and self-help strategies Before engaging in any of the below, its important to talk with your professional care team

Article | July 24, 2025 Trimming time: metabolomics insights to speed development of GLP-1 therapies Multiple GLP-1-based therapies for type 2 diabetes and obesity have been approved in recent years, reflecting their strong clinical effectiveness in improving glycemic control

The change sets a dangerous precedent by creating two classes of drug coverage for TRICARE and TRICARE For Life beneficiaries